JPWO2018201192A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2018201192A5
JPWO2018201192A5 JP2019560254A JP2019560254A JPWO2018201192A5 JP WO2018201192 A5 JPWO2018201192 A5 JP WO2018201192A5 JP 2019560254 A JP2019560254 A JP 2019560254A JP 2019560254 A JP2019560254 A JP 2019560254A JP WO2018201192 A5 JPWO2018201192 A5 JP WO2018201192A5
Authority
JP
Japan
Prior art keywords
carbon atoms
heteroatom
heterocyclic
heterocyclyl
term
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019560254A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020518621A (ja
JP7788128B2 (ja
JP2020518621A5 (enExample
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050404 external-priority patent/WO2018201192A1/en
Publication of JP2020518621A publication Critical patent/JP2020518621A/ja
Publication of JP2020518621A5 publication Critical patent/JP2020518621A5/ja
Priority to JP2023101906A priority Critical patent/JP2023134493A/ja
Publication of JPWO2018201192A5 publication Critical patent/JPWO2018201192A5/ja
Application granted granted Critical
Publication of JP7788128B2 publication Critical patent/JP7788128B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560254A 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物 Active JP7788128B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023101906A JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2017901611A AU2017901611A0 (en) 2017-05-03 Compounds for the treatment of respiratory diseases
AU2017901611 2017-05-03
AU2017901647A AU2017901647A0 (en) 2017-05-05 Compounds for the treatment of respiratory diseases
AU2017901647 2017-05-05
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023101906A Division JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Publications (4)

Publication Number Publication Date
JP2020518621A JP2020518621A (ja) 2020-06-25
JP2020518621A5 JP2020518621A5 (enExample) 2021-05-27
JPWO2018201192A5 true JPWO2018201192A5 (enExample) 2025-04-14
JP7788128B2 JP7788128B2 (ja) 2025-12-18

Family

ID=64015663

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560254A Active JP7788128B2 (ja) 2017-05-03 2018-05-03 呼吸器疾患の治療のための化合物
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023101906A Withdrawn JP2023134493A (ja) 2017-05-03 2023-06-21 呼吸器疾患の治療のための化合物

Country Status (9)

Country Link
US (2) US20200079757A1 (enExample)
EP (1) EP3619204B1 (enExample)
JP (2) JP7788128B2 (enExample)
CN (1) CN110753688A (enExample)
AU (3) AU2018262108A1 (enExample)
ES (1) ES3049333T3 (enExample)
FI (1) FI3619204T3 (enExample)
PT (1) PT3619204T (enExample)
WO (1) WO2018201192A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113350352B (zh) 2015-03-23 2024-09-10 天莅生物科技私人有限公司 呼吸性疾病的治疗
WO2020093097A1 (en) * 2018-11-07 2020-05-14 The University Of Melbourne Compounds and compositions for the treatment of respiratory diseases
CN110452880B (zh) * 2019-09-09 2021-09-21 温州医科大学附属第一医院 急性肺损伤细胞模型的制备方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL110296A (en) * 1993-07-16 1999-12-31 Smithkline Beecham Corp Imidazole compounds process for their preparation and pharmaceutical compositions containing them
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
CA2314980A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
IN2012DN03182A (enExample) * 2009-10-28 2015-09-25 Pfizer
CZ2012538A3 (cs) * 2012-08-08 2014-02-19 Masarykova Univerzita Inhibitory pro léčbu B-buněčné chronické lymfocytární leukémie
CN113350352B (zh) * 2015-03-23 2024-09-10 天莅生物科技私人有限公司 呼吸性疾病的治疗

Similar Documents

Publication Publication Date Title
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
UY29421A1 (es) Nuevos compuestos de n-(n-sulfonilaminoarilmetil) ciclopropanocarboxanida sustituidos, comoposiciones farmacéuticas que los contienen a aplicaciones.
AR040351A1 (es) Derivados de quinuclidina-amida, composicion farmaceutica, procedimiento de preparacion del compuesto y su uso para fabricar medicamentos
UY29389A1 (es) Derivados sustituidos del ácido1-((4-((((3,3-dimetil-2-oxo-2,3-dihidro-1h-indol-1-il)carbonil)amino)metil)piperidin-1-il)metil)ciclobutanocarboxílico, sales farmaceuticamente aceptables, composiciones que los contienen y aplicaciones.
JP7233059B2 (ja) 結核に対する薬剤と組み合わせた環融合型チアゾリノ２－ピリドン
UY28961A1 (es) Derivados de ácido carboxílico de bencimidazolona antecedentes de la invención
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
JPWO2018201192A5 (enExample)
US20210251942A1 (en) 2-naphthimidamides, analogues thereof, and methods of treatment using same
DK239788A (da) Beta-d-phenyl-thioxylosider, fremgangsmaade til deres fremstilling og deres anvendelse som terapeutika
BRPI0509390A (pt) derivados de 1-(1h-indol-1-il)-3-(4-metilpiperazin-1-il)-fenil propan-2-ol e compostos relacionados como moduladores da atividade da norepinefrina (ne) e da serotonina (5-th) e da reabsorção da monoamina para o tratamento de sintomas vasomotores (vms)
SE7709784L (sv) Heterocykliska derivat
DE602006010563D1 (de) Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors
KR20050086933A (ko) 브롬화수소산에스시탈로프람 및 이의 제조방법
Sabbah et al. A new route towards fimbrolide analogues: importance of the exomethylene motif in LuxR dependent quorum sensing inhibition
JP4485746B2 (ja) ニコチン性アセチルコリンレセプターリガンドおよび／またはセロトニン作動性リガンドとしての６Ｈ−オキサゾロ［４，５−ｅ］インドール誘導体
EA200700807A1 (ru) Новые циклические и ациклические пропеноны для лечения заболеваний цнс
JP5621037B2 (ja) アルキルジアミン類誘導体及びその抗うつ薬としての使用
EA200702626A1 (ru) Новые замещённые тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена и их применение в качестве лекарственного средства
TR200909787A2 (tr) Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
NO330989B1 (no) Nye piperazinderivater, fremgangsmater for fremstilling av slike og deres anvendelse som syntesemellomprodukter.
MXPA02005092A (es) Nuevas sulfoniloxazolaminas.
GB851692A (en) Hydrogenation of oxyheterocyclic compounds
SU471106A1 (ru) Способ очистки технологического газа от высококип щих примесей
CU20070183A7 (es) Derivados de oxindol